Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.

Goldie SJ, Freedberg KA, Weinstein MC, Wright TC, Kuntz KM.

Am J Med. 2001 Aug;111(2):140-9.

PMID:
11498068
2.

Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.

Franco EL.

J Natl Cancer Inst Monogr. 2003;(31):89-96. Review.

PMID:
12807951
3.

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.

Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N.

Health Technol Assess. 2004 May;8(20):iii, 1-78. Review.

4.

Screening for cervical cancer: new alternatives and research.

Lörincz AT.

Salud Publica Mex. 2003;45 Suppl 3:S376-87. Review.

PMID:
14746031
5.

[Human papillomavirus and screening for cervical cancer: state of art and prospects].

Meijer CJ, Rozendaal L, Voorhorst FJ, Verheijen R, Helmerhorst TJ, Walboomers JM.

Ned Tijdschr Geneeskd. 2000 Aug 26;144(35):1675-9. Review. Dutch.

PMID:
10981235
6.
7.

The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.

Holmes J, Hemmett L, Garfield S.

Eur J Health Econ. 2005 Mar;6(1):30-7. Review.

PMID:
15682286
8.

Chapter 15: Public health policy and cost-effectiveness analysis.

Goldie SJ.

J Natl Cancer Inst Monogr. 2003;(31):102-10. Review.

PMID:
12807953
9.

[Can human papillomavirus testing and vaccination prevent cervical cancer?].

Lie AK, Bjørge T, Helland A, Hagen B, Skjeldestad FE, Hagmar B, Thoresen S.

Tidsskr Nor Laegeforen. 2001 Oct 20;121(25):2947-51. Review. Norwegian.

PMID:
11715778
10.

Diagnosing human papillomaviruses: recent advances.

Jenkins D.

Curr Opin Infect Dis. 2001 Feb;14(1):53-62. Review.

PMID:
11979116
11.

Primary screening for human papillomavirus infection.

Dillner J.

Best Pract Res Clin Obstet Gynaecol. 2001 Oct;15(5):743-57. Review.

PMID:
11563870
12.

Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs.

Lörincz AT, Richart RM.

Arch Pathol Lab Med. 2003 Aug;127(8):959-68. Review.

PMID:
12873167
13.

Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer.

Czoski-Murray C, Karnon J, Jones R, Smith K, Kinghorn G.

Health Technol Assess. 2010 Nov;14(53):iii-iv, ix-x, 1-101. doi: 10.3310/hta14530. Review.

14.

[Papillomavirus screening: shall it be performed systematically?].

Agius G, Beby-Defaux A.

Transfus Clin Biol. 2003 Apr;10(2):86-9. Review. French. No abstract available.

PMID:
12763151
15.

Human papillomavirus testing for primary cervical cancer screening.

Grce M, Davies P.

Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599. Review.

PMID:
18785808
16.

Role of routine human papillomavirus subtyping in cervical screening.

Goodman A.

Curr Opin Obstet Gynecol. 2000 Feb;12(1):11-4. Review.

PMID:
10752510
17.

[Population screening for cervical cancer; eventual gain not expected to increase by testing for papillomavirus].

Giard RW, Coebergh JW.

Ned Tijdschr Geneeskd. 2000 Aug 26;144(35):1664-8. Review. Dutch.

PMID:
10981232
18.

Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection.

Palefsky JM.

J Acquir Immune Defic Syndr. 1999 Aug 1;21 Suppl 1:S42-8. Review.

PMID:
10430218
19.

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions.

Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, van Ballegooijen M, van den Akker-van Marle E.

Br J Cancer. 2000 Sep;83(5):561-5. Review.

20.

Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.

Tota J, Mahmud SM, Ferenczy A, Coutlée F, Franco EL.

Sex Health. 2010 Sep;7(3):376-82. doi: 10.1071/SH10022. Review.

PMID:
20719230
Items per page

Supplemental Content

Support Center